kpix-7-2013-masthead kcbs 7-2013-masthead

Gilead Sciences

Sovaldi

Foster City-Based Gilead’s Breakthrough Hepatitis Drug Costs $1,000 Per Pill

Doctors are calling a newly-approved drug a “ revolution” in treating the most common blood-borne infection in the United States. But patient advocates warn how those who need it may not be able to afford it; and noisy protests from Paris to San Francisco are trying to drive the displeasure over the price into the open.

02/18/2014

(CBS)

FDA Rejects 2 HIV Drugs From Gilead Sciences

Gilead Sciences said Monday that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the Foster Citry company’s manufacturing facilities.

04/29/2013

Stribild, AIDS Drug, Gilead Sciences

SF Ballot Measure Sought To Fight Pricing Of New AIDS Drug

The AIDS Healthcare Foundation is spearheading a ballot measure in San Francisco to combat what it calls “predatory pricing” of a new AIDS drug.

08/30/2012

Bottles of antiretroviral drug Truvada are displayed at Jack's Pharmacy on November 23, 2010 in San Anselmo, California. (Justin Sullivan/Getty Images)

FDA Approves Foster City Company’s Pill To Help Prevent HIV

The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.

07/16/2012

Bottles of antiretroviral drug Truvada are displayed at Jack's Pharmacy on November 23, 2010 in San Anselmo, California. (Justin Sullivan/Getty Images)

UC Scientists Testing HIV Prevention Pill

The UC-based California HIV/AIDS Research Program (CHRP) has awarded grants totaling $11.8 million to see if a current HIV drug can be used to prevent the onset of the virus.

04/18/2012